Institut für Klinische Chemie und Laboratoriumsmedizin
Klinikum / Johannes Gutenberg-Universität Mainz
Forschungsprojekte
Ergebnisse pro Seite:
10
2022 - 2026
A Phase III Randomized, Open-Label, Multicenter Study to Determine the Efficacy and Safety of Durvalumab in Combination With Tremelimumab and Enfortumab Vedotin or Durvalumab in Combination With Enfortumab Vedotin for Perioperative Treatment in Patients Ineligible for Cisplatin or Who Refuse Cisplatin Undergoing Radical Cystectomy for Muscle InvasiveBladder Cancer (VOLGA)- PD Dr. med. Maximilian,
- PD Dr. Rene,
- Dr. Anita
2022 - 2024
A Randomized Open Label Phase 1/2 Study of INCB001158 Combined With Subcutaneous (SC) Daratumumab, Compared To Daratumumab SC, in Participants With Relapsed or Refractory Multiple Myeloma- Dr. med. Markus,
- Prof. Dr. med. Georg
2021 - 2029
ALLTogether1 – A Treatment study protocol of the ALLTogether Consortium for children and young adults (1-45 years of age) with newly diagnosed acute lymphoblastic leukaemia (ALL)- Univ.-Prof. Dr. med. Jörg,
- Dr. med. Arthur,
- Dr. med. Alexandra
2018 - 2019
FORT-1:Phase 2/3 study of rogaratinib (BAY 1163877) vs chemotherapy in patients with FGFR-positive locally advanced or metastatic urothelial carcinoma- Prof. Dr. Georg,
- Prof. Dr. Igor,
- PD Dr. Thomas
2018 - 2022
FORT-2: Phase 1b/2 study of rogaratinib (BAY 1163877) in combination with atezolizumab in urothelial carcinoma- Prof. Dr. Georg,
- Prof. Dr. Igor,
- PD Dr. Thomas
2016 - 2017
Adapting conCLIP to illuminate the role of RNA-binding proteins (RBPs) in pathophysiological processes- Prof. Dr. Sven
2014 - 2015
Untersuchungen über die Bedeutung der von-Willebrand-Faktor-Parameter sowie ADAMTS13 zur Pathogenese der Arteriosklerose bei chronischen Schmerzpatienten- Univ.-Prof. Dr. Inge,
- Dr. Rita,
- Univ.-Prof. Dr. Christian